FOXM1 and leukemia: These results showed that in leukemia cells but not in wildtype hematopoietic stem/progenitor cells Foxm1 stabilized β-catenin protein by inhibiting polyubiquitination of β-catenin, thereby preventing its degradation by proteasomes.